News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ParinGenix Inc. Gets FDA Approval Of IND For PGX-100


10/19/2005 5:12:39 PM

TUCSON, Ariz.--(BUSINESS WIRE)--Feb. 9, 2005--ParinGenix Inc., an early stage drug development company, has received approval of its Investigational New Drug (IND) application for its drug, PGX-100, from the U.S. Food and Drug Administration Division of Cardio-Renal Drug Products.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES